PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
Qazilbash MH, Wieder E, Thall PF, Wang X, Rios R, Lu S, Kanodia S, Ruisaard KE, Giralt SA, Estey EH, Cortes J, Komanduri KV, Clise-Dwyer K, Alatrash G, Ma Q, Champlin RE, Molldrem JJ.
Qazilbash MH, et al. Among authors: estey eh.
Leukemia. 2017 Mar;31(3):697-704. doi: 10.1038/leu.2016.254. Epub 2016 Sep 22.
Leukemia. 2017.
PMID: 27654852
Free PMC article.